e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Altimmune Inc
Recent news which mentions Altimmune Inc
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Health care industry
Altimmune Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Oracle Corp
UnitedHealth Group Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Gilead Sciences Inc
Healthy Returns
Zealand Pharma A/S
From
CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags
Science
Health & Science
Pharmaceuticals
From
CNBC.com News
Cramer's Lightning Round: Quanta Services is 'terrific'
May 06, 2024
Tags
Business
Investment strategy
S&P 500
From
CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
March 27, 2024
Tags
Novo Nordisk A/S
Companies
Biotechnology
From
CNBC.com News
Cramer's Lightning Round: Datadog is a 'dynamite company'
March 18, 2024
Tags
U/S/ Markets
Marvell Technology Inc
Altimmune Inc
From
CNBC.com News
Cramer's Lightning Round: Affirm is a buy
February 12, 2024
Tags
Business News
Markets
Darling Ingredients Inc
From
CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
Tags
US: News
Business
Eli Lilly and Co
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.